Bio-Data-16-01 Using Novel Objective Bio-Data To Improve Quality Of Life Assessment In Patients Undergoing Cytotoxic Chemotherapy: An Interventional Pilot Study
Posted Date: Jun 11, 2019
- Investigator: Thomas Herzog
- Specialties: Breast Cancer, Cancer, Gynecologic Oncology, Lung Cancer, Oncology, Ovarian Cancer
- Type of Study: Device
The goal of this study is to capture on-treatment objective quantification of physical activity/ bio-data (steps, calories, standing time) and sleep patterns and cycles in patients receiving chemotherapy front-line for breast, lung, and ovarian cancer, and to record the impact of therapy on quality of life.
To Be Eligible: Must Be A Female With Breast, Lung, Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer. Ecog Performance Of 0,1, Or 2, Patients Who Will Undergo At Least 3 Cycles Of Chemotherapy.
Breast Cancer, Ovarian Cancer, Lung Cancer
For More Information:
Uc Cancer Institute